Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
24850 | 299 | 35.7 | 80% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
317 | 3 | HER2//TRASTUZUMAB//CHRONIC MYELOID LEUKEMIA | 39408 |
1452 | 2 | CHRONIC MYELOID LEUKEMIA//IMATINIB//NILOTINIB | 7818 |
24850 | 1 | TYRPHOSTIN//AG957//INOSTAMYCIN | 299 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | TYRPHOSTIN | authKW | 852356 | 13% | 22% | 38 |
2 | AG957 | authKW | 510623 | 2% | 100% | 5 |
3 | INOSTAMYCIN | authKW | 454913 | 2% | 64% | 7 |
4 | ADAPHOSTIN | authKW | 408494 | 2% | 67% | 6 |
5 | MOL LEVEL INTER E MIRC | address | 204249 | 1% | 100% | 2 |
6 | STYRYL DIPHENYLAMINE DERIVATIVE | authKW | 204249 | 1% | 100% | 2 |
7 | ERBSTATIN | authKW | 204241 | 2% | 33% | 6 |
8 | 1 BENZYLIDENE 3 4 DIHYDRO 1H 6H 1 4OXAZINO 3 4 B QUINAZOLIN 6 ONES 1 PHENYLHYDRAZONO 3 4 DIHYDRO 1H 6H 1 4OXA | authKW | 102125 | 0% | 100% | 1 |
9 | 17 DEMETHOXYGELDANAMYCIN | authKW | 102125 | 0% | 100% | 1 |
10 | 3 5 DISUBSTITUTED 1 3 4 OXADIAZOL 23H ONE DERIVATIVES | authKW | 102125 | 0% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Chemistry, Medicinal | 1229 | 19% | 0% | 58 |
2 | Oncology | 693 | 26% | 0% | 78 |
3 | Pharmacology & Pharmacy | 530 | 26% | 0% | 78 |
4 | Biochemistry & Molecular Biology | 310 | 29% | 0% | 88 |
5 | Biophysics | 136 | 9% | 0% | 26 |
6 | Cell Biology | 104 | 11% | 0% | 34 |
7 | Chemistry, Organic | 48 | 7% | 0% | 22 |
8 | Biotechnology & Applied Microbiology | 13 | 4% | 0% | 13 |
9 | Biochemical Research Methods | 8 | 3% | 0% | 8 |
10 | Immunology | 5 | 4% | 0% | 12 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MOL LEVEL INTER E MIRC | 204249 | 1% | 100% | 2 |
2 | ALBERT SILBERMAN LIFE SCI BIOL CHEM | 102125 | 0% | 100% | 1 |
3 | BIOCHEM MIHAMA KU | 102125 | 0% | 100% | 1 |
4 | BIOL SCI TECHNOLLIFE SYST | 102125 | 0% | 100% | 1 |
5 | CLIN IMMUNOENDOCRINOL | 102125 | 0% | 100% | 1 |
6 | CLIN TIALS UNIT | 102125 | 0% | 100% | 1 |
7 | ONCOL VIROL PHARMACEUT K125420 | 102125 | 0% | 100% | 1 |
8 | PHARMACOL EXPT THER EUT SECTDEV THER EUT PRO | 102125 | 0% | 100% | 1 |
9 | SREENING TECHNOL BRANCH | 102125 | 0% | 100% | 1 |
10 | UNIT CELL DIFFENTIAT CANC | 102125 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ANTI-CANCER DRUG DESIGN | 16268 | 3% | 2% | 10 |
2 | JOURNAL OF MEDICINAL CHEMISTRY | 1200 | 5% | 0% | 16 |
3 | JAPANESE JOURNAL OF CANCER RESEARCH | 1029 | 2% | 0% | 6 |
4 | JOURNAL OF ANTIBIOTICS | 971 | 3% | 0% | 8 |
5 | TOPICS IN CURRENT CHEMISTRY-SERIES | 926 | 0% | 1% | 1 |
6 | DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH | 880 | 1% | 0% | 4 |
7 | ADVANCES IN ENZYME REGULATION | 681 | 1% | 0% | 2 |
8 | CURRENT SIGNAL TRANSDUCTION THERAPY | 469 | 0% | 0% | 1 |
9 | PHYSIOLOGY AND MOLECULAR BIOLOGY OF PLANTS | 413 | 0% | 0% | 1 |
10 | NIPPON NOGEIKAGAKU KAISHI-JOURNAL OF THE JAPAN SOCIETY FOR BIOSCIENCE BIOTECHNOLOGY AND AGROCHEMISTRY | 393 | 1% | 0% | 2 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | LEVITZKI, A , GAZIT, A , (1995) TYROSINE KINASE INHIBITION - AN APPROACH TO DRUG DEVELOPMENT.SCIENCE. VOL. 267. ISSUE 5205. P. 1782-1788 | 28 | 32% | 1403 |
2 | LEVITZKI, A , (1999) PROTEIN TYROSINE KINASE INHIBITORS AS NOVEL THERAPEUTIC AGENTS.PHARMACOLOGY & THERAPEUTICS. VOL. 82. ISSUE 2-3. P. 231 -239 | 21 | 43% | 166 |
3 | LEVITZKI, A , (2002) TYROSINE KINASES AS TARGETS FOR CANCER THERAPY.EUROPEAN JOURNAL OF CANCER. VOL. 38. ISSUE . P. S11-S18 | 18 | 40% | 64 |
4 | SMYTH, MS , STEFANOVA, I , HARTMANN, F , HORAK, ID , OSHEROV, N , LEVITZKI, A , BURKE, TR , (1993) NON-AMINE BASED ANALOGS OF LAVENDUSTIN-A AS PROTEIN-TYROSINE KINASE INHIBITORS.JOURNAL OF MEDICINAL CHEMISTRY. VOL. 36. ISSUE 20. P. 3010-3014 | 15 | 68% | 35 |
5 | CHEN, HX , BOIZIAU, J , PARKER, F , MAILLIET, P , COMMERCON, A , TOCQUE, B , LEPECQ, JB , ROQUES, BP , GARBAY, C , (1994) STRUCTURE-ACTIVITY-RELATIONSHIPS IN A SERIES OF 5-[(2,5-DIHYDROXYBENZYL)AMINO]SALICYLATE INHIBITORS OF EGF-RECEPTOR-ASSOCIATED TYROSINE KINASE - IMPORTANCE OF ADDITIONAL HYDROPHOBIC AROMATIC INTERACTIONS.JOURNAL OF MEDICINAL CHEMISTRY. VOL. 37. ISSUE 6. P. 845-859 | 20 | 50% | 22 |
6 | HOFFMAN, R , DENNIS, IF , DONALDSON, J , (1995) PROTEIN-BINDING MODULATES INHIBITION OF THE EPIDERMAL GROWTH-FACTOR RECEPTOR KINASE AND DNA-SYNTHESIS BY TYRPHOSTINS.CANCER CHEMOTHERAPY AND PHARMACOLOGY. VOL. 36. ISSUE 4. P. 316-324 | 14 | 67% | 2 |
7 | KAUR, G , NARAYANAN, VL , RISBOOD, PA , HOLLINGSHEAD, MG , STINSON, SF , VARMA, RK , SAUSVILLE, EA , (2005) SYNTHESIS, STRUCTURE-ACTIVITY RELATIONSHIP, AND P210(BCR-ABL) PROTEIN TYROSINE KINASE ACTIVITY OF NOVEL AG 957 ANALOGS.BIOORGANIC & MEDICINAL CHEMISTRY. VOL. 13. ISSUE 5. P. 1749-1761 | 12 | 50% | 14 |
8 | LEVITZKI, A , (1992) TYRPHOSTINS - TYROSINE KINASE BLOCKERS AS NOVEL ANTIPROLIFERATIVE AGENTS AND DISSECTORS OF SIGNAL TRANSDUCTION.FASEB JOURNAL. VOL. 6. ISSUE 14. P. 3275-3282 | 18 | 32% | 293 |
9 | LEVITZKI, A , (2001) PROTEIN TYROSINE KINASE INHIBITORS AS THERAPEUTIC AGENTS.BIOORGANIC CHEMISTRY OF BIOLOGICAL SIGNAL TRANSDUCTION. VOL. 211. ISSUE . P. 1 -15 | 17 | 33% | 12 |
10 | HORI, H , NAGASAWA, H , ISHIBASHI, M , UTO, Y , HIRATA, A , SAIJO, K , OHKURA, K , KIRK, KL , UEHARA, Y , (2002) TX-1123: AN ANTITUMOR 2-HYDROXYARYLIDENE-4-CYCLOPENTENE-1,3-DIONE AS A PROTEIN TYROSINE KINASE INHIBITOR HAVING LOW MITOCHONDRIAL TOXICITY.BIOORGANIC & MEDICINAL CHEMISTRY. VOL. 10. ISSUE 10. P. 3257-3265 | 12 | 44% | 28 |
Classes with closest relation at Level 1 |